<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938097/" ref="ordinalpos=2396&amp;ncbi_uid=3059917&amp;link_uid=PMC2938097" image-link="/pmc/articles/PMC2938097/figure/F9/" class="imagepopup">Fig. 9. From: Studies of Phosphoproteomic Changes Induced by Nucleophosmin-Anaplastic Lymphoma Kinase (ALK) Highlight Deregulation of Tumor Necrosis Factor (TNF)/Fas/TNF-related Apoptosis-induced Ligand <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> in ALK-positive Anaplastic Large Cell Lymphoma. </a></div><br /><div class="p4l_captionBody"><b>Validation of phosphoproteins involved in TNF/Fas/TRAIL signaling pathway using ALK+ ALCL cell lines.</b> The immunoprecipitation (IP) experiments were performed using Karpas 299 and SU-DH-L1, two well studied ALK+ ALCL cell lines, with anti-TRAP1 antibody (A), anti-RIP antibody (B), and anti-FAF1 antibody (C). The phosphorylation statuses of these three proteins were detected by using anti-phosphotyrosine antibody. The immunoprecipitation experiments without antibody were used as control experiments. IB, immunoblot; phos, phospho.</div></div>